New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease

Learn how experts select and carefully consider the toxicity profiles of established and newly emerging androgen-deprivation therapies toward the optimal management of patients with castration-sensitive prostate cancer. Download slides from the live symposium and read an expert-authored commentary on androgen-deprivation therapies for castration-sensitive prostate cancer.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Myovant Sciences Inc

Pfizer, Inc.